Data Sheet 1_How to optimize the CAR-T Cell therapy process? A group concept mapping analysis of preconditions for a frictionless process from a German multistakeholder perspective.docx

Data Sheet 1_How to optimize the CAR-T Cell therapy process? A group concept mapping analysis of preconditions for a frictionless process from a German multistakeholder perspective.docx

Introduction<p>Treatment with chimeric antigen receptor T (CAR-T) cells involves a large number of interdisciplinary stakeholders and is associated with complex processes ranging from patient-specific production to follow-up care. Due to the complexity, maximum process optimization is required...

Full description

Saved in:
Bibliographic Details
Main Author: Ann-Cathrine Siefen (19724086) (author)
Other Authors: Melina Sophie Kurte (19724089) (author), Florian Jakobs (19724092) (author), Marcel Teichert (19724095) (author), Bastian von Tresckow (14404803) (author), Hans Christian Reinhardt (10038563) (author), Udo Holtick (17430017) (author), Johannes Atta (19724098) (author), Christian Jehn (19724101) (author), Elisa Sala (2312704) (author), Anke Warnecke (19724104) (author), Mathias Hänel (6884777) (author), Christof Scheid (19081) (author), Florian Kron (7321391) (author)
Published: 2024
Subjects:
Oncology and Carcinogenesis not elsewhere classified
CAR-T
hematology
cluster map
mixed-methods
barriers
process optimization
group concept mapping
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items